CLINICAL_TRIALS
trial_result
· 2017-01-12
Clinical Trial Update: Effects of Labetalol on Nicotine Administration in Humans - 14 [Phase 2]
Summary
A Phase 2 study evaluating the effects of the beta-blocker labetalol on nicotine administration for tobacco use disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED